qatar bloodstock limited
qatar bloodstock limited Company Information
Company Number
07422602
Next Accounts
Sep 2025
Industry
Other retail sale not in stores, stalls or markets
Shareholders
qatar investment & projects development holding co.
Group Structure
View All
Contact
Registered Address
lushington house, 119 high street, newmarket, suffolk, CB8 9AE
Website
www.qatarracingltd.comqatar bloodstock limited Estimated Valuation
Pomanda estimates the enterprise value of QATAR BLOODSTOCK LIMITED at £1.4m based on a Turnover of £17.7m and 0.08x industry multiple (adjusted for size and gross margin).
qatar bloodstock limited Estimated Valuation
Pomanda estimates the enterprise value of QATAR BLOODSTOCK LIMITED at £0 based on an EBITDA of £-2.2m and a 0.9x industry multiple (adjusted for size and gross margin).
qatar bloodstock limited Estimated Valuation
Pomanda estimates the enterprise value of QATAR BLOODSTOCK LIMITED at £0 based on Net Assets of £-3.5m and 2.93x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Qatar Bloodstock Limited Overview
Qatar Bloodstock Limited is a live company located in newmarket, CB8 9AE with a Companies House number of 07422602. It operates in the other retail sale not in stores, stalls or markets sector, SIC Code 47990. Founded in October 2010, it's largest shareholder is qatar investment & projects development holding co. with a 100% stake. Qatar Bloodstock Limited is a established, mid sized company, Pomanda has estimated its turnover at £17.7m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Qatar Bloodstock Limited Health Check
Pomanda's financial health check has awarded Qatar Bloodstock Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs
3 Strong
2 Regular
6 Weak
Size
annual sales of £17.7m, make it larger than the average company (£2.5m)
£17.7m - Qatar Bloodstock Limited
£2.5m - Industry AVG
Growth
3 year (CAGR) sales growth of 9%, show it is growing at a similar rate (9.4%)
9% - Qatar Bloodstock Limited
9.4% - Industry AVG
Production
with a gross margin of -20%, this company has a higher cost of product (31.3%)
-20% - Qatar Bloodstock Limited
31.3% - Industry AVG
Profitability
an operating margin of -13.1% make it less profitable than the average company (4.3%)
-13.1% - Qatar Bloodstock Limited
4.3% - Industry AVG
Employees
with 3 employees, this is below the industry average (16)
3 - Qatar Bloodstock Limited
16 - Industry AVG
Pay Structure
on an average salary of £54.8k, the company has a higher pay structure (£38.4k)
£54.8k - Qatar Bloodstock Limited
£38.4k - Industry AVG
Efficiency
resulting in sales per employee of £5.9m, this is more efficient (£232.5k)
£5.9m - Qatar Bloodstock Limited
£232.5k - Industry AVG
Debtor Days
it gets paid by customers after 28 days, this is near the average (33 days)
28 days - Qatar Bloodstock Limited
33 days - Industry AVG
Creditor Days
its suppliers are paid after 50 days, this is slower than average (37 days)
50 days - Qatar Bloodstock Limited
37 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Qatar Bloodstock Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 2 weeks, this is less cash available to meet short term requirements (22 weeks)
2 weeks - Qatar Bloodstock Limited
22 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 105.9%, this is a higher level of debt than the average (61.3%)
105.9% - Qatar Bloodstock Limited
61.3% - Industry AVG
QATAR BLOODSTOCK LIMITED financials
Qatar Bloodstock Limited's latest turnover from December 2023 is £17.7 million and the company has net assets of -£3.5 million. According to their latest financial statements, Qatar Bloodstock Limited has 3 employees and maintains cash reserves of £2.5 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 17,674,541 | 16,075,646 | 14,181,165 | 13,724,354 | 18,978,377 | 15,723,114 | 18,078,735 | 15,812,067 | 10,406,675 | 12,178,991 | 6,492,896 | 7,659,340 | 5,983,722 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost Of Sales | 21,207,602 | 15,035,293 | 16,291,811 | 12,365,323 | 53,009,991 | -1,210,456 | 17,634,060 | 9,449,938 | 14,163,949 | 13,762,640 | 4,572,265 | 4,391,016 | 4,512,040 |
| Gross Profit | -3,533,061 | 1,040,353 | -2,110,646 | 1,359,031 | -34,031,614 | 16,933,570 | 444,675 | 6,362,129 | -3,757,274 | -1,583,649 | 1,920,631 | 3,268,324 | 1,471,682 |
| Admin Expenses | -1,225,517 | 1,101,984 | 1,160,689 | 2,149,532 | -22,608,836 | -116,389,135 | -619,006 | 1,189,056 | 1,846,957 | 1,122,744 | 733,053 | 294,969 | 224,280 |
| Operating Profit | -2,307,544 | -61,631 | -3,271,335 | -790,501 | -11,422,778 | 133,322,705 | 1,063,681 | 5,173,073 | -5,604,231 | -2,706,393 | 1,187,578 | 2,973,355 | 1,247,402 |
| Interest Payable | 0 | 0 | 0 | 0 | 285,500 | 0 | 317,893 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Receivable | 121,371 | 163,064 | 97,143 | 119,830 | 59,967 | 18,178 | 0 | 250,139 | 250,888 | 250,669 | 203,142 | 0 | 0 |
| Pre-Tax Profit | -2,186,173 | 101,433 | -3,174,192 | -670,671 | -11,648,311 | 13,382,355 | 745,788 | 5,423,212 | -5,353,343 | -2,455,724 | 1,390,720 | 2,973,355 | 1,247,402 |
| Tax | -401,155 | -1,113 | -109,740 | -31,633 | -1,289 | -544,376 | -927 | 0 | 10,891 | 0 | 33,525 | -46,419 | -155,499 |
| Profit After Tax | -2,587,328 | 100,320 | -3,283,932 | -702,304 | -11,649,600 | 12,837,979 | 744,861 | 5,423,212 | -5,342,452 | -2,455,724 | 1,424,245 | 2,926,936 | 1,091,903 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | -2,587,328 | 100,320 | -3,283,932 | -702,304 | -11,649,600 | 12,837,979 | 744,861 | 5,423,212 | -5,342,452 | -2,455,724 | 1,424,245 | 2,926,936 | 1,091,903 |
| Employee Costs | 164,508 | 209,245 | 74,227 | 152,703 | 235,738 | 145,762 | 215,982 | 32,944 | 35,435 | 6,167 | 117,662 | ||
| Number Of Employees | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | ||
| EBITDA* | -2,213,228 | 32,681 | -3,177,258 | -689,742 | -11,320,405 | 133,405,938 | 1,135,820 | 5,237,406 | -5,549,293 | -2,686,410 | 1,187,578 | 2,973,355 | 1,247,402 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 2,460,633 | 2,554,949 | 2,646,871 | 2,740,950 | 2,897,587 | 2,909,071 | 2,248,590 | 1,717,273 | 1,651,013 | 1,655,939 | 1,038,295 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 338,965 | 381,411 | 422,140 | 500,000 | 0 | 0 | 0 | 0 | 0 | 12,157,491 | 0 | 0 | 0 |
| Total Fixed Assets | 2,799,598 | 2,936,360 | 3,069,011 | 3,240,950 | 2,897,587 | 2,909,071 | 2,248,590 | 1,717,273 | 1,651,013 | 13,813,430 | 1,038,295 | 0 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 42,791,249 | 81,025,316 | 39,052,055 | 41,574,957 | 39,510,578 | 37,737,749 | 38,330,113 | 22,858,190 | 18,256,763 |
| Trade Debtors | 1,392,896 | 2,289,017 | 2,174,966 | 1,766,537 | 1,807,290 | 2,373,804 | 1,065,446 | 2,123,781 | 1,627,500 | 1,866,093 | 4,009,185 | 1,497,530 | 2,979,624 |
| Group Debtors | 14,740,328 | 6,752,707 | 2,921,954 | 643,965 | 2,962,232 | 445,500 | 18,358,791 | 15,133,082 | 8,898,680 | 4,913,833 | 4,796,222 | 4,942,896 | 405,050 |
| Misc Debtors | 1,434,395 | 1,532,321 | 1,630,716 | 1,453,533 | 1,167,194 | 3,395,168 | 2,254,040 | 579,119 | 3,289,391 | 1,104,365 | 1,511,379 | 276,173 | 338,057 |
| Cash | 2,512,737 | 1,764,010 | 3,167,207 | 3,035,178 | 14,439,315 | 3,480,892 | 1,837,034 | 560,767 | 735,986 | 1,331,471 | 1,728,063 | 1,263,729 | 1,442,681 |
| misc current assets | 36,939,442 | 48,727,843 | 50,329,819 | 56,181,059 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 57,019,798 | 61,065,898 | 60,224,662 | 63,080,272 | 63,167,280 | 90,720,680 | 62,567,366 | 59,971,706 | 54,062,135 | 46,953,511 | 50,374,962 | 30,838,518 | 23,422,175 |
| total assets | 59,819,396 | 64,002,258 | 63,293,673 | 66,321,222 | 66,064,867 | 93,629,751 | 64,815,956 | 61,688,979 | 55,713,148 | 60,766,941 | 51,413,257 | 30,838,518 | 23,422,175 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 2,914,990 | 2,489,377 | 1,889,155 | 2,327,204 | 634,492 | 4,565,764 | 1,797,940 | 1,876,883 | 1,694,946 | 3,886,208 | 4,283,591 | 3,055,702 | 2,294,048 |
| Group/Directors Accounts | 59,497,679 | 59,781,266 | 59,815,812 | 58,465,081 | 57,875,904 | 70,734,583 | 58,127,736 | 55,149,632 | 54,917,133 | 53,451,777 | 516,024 | 1,295,500 | 282,929 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 936,865 | 1,894,712 | 1,562,527 | 1,928,899 | 2,977,376 | 2,094,272 | 1,411,091 | 1,594,343 | 1,456,160 | 441,595 | 13,000 | 171,516 | 456,335 |
| total current liabilities | 63,349,534 | 64,165,355 | 63,267,494 | 62,721,184 | 61,487,772 | 77,394,619 | 61,336,767 | 58,620,858 | 58,068,239 | 57,779,580 | 4,812,615 | 4,522,718 | 3,033,312 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41,157,557 | 22,296,960 | 19,296,959 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41,157,557 | 22,296,960 | 19,296,959 |
| total liabilities | 63,349,534 | 64,165,355 | 63,267,494 | 62,721,184 | 61,487,772 | 77,394,619 | 61,336,767 | 58,620,858 | 58,068,239 | 57,779,580 | 45,970,172 | 26,819,678 | 22,330,271 |
| net assets | -3,530,138 | -163,097 | 26,179 | 3,600,038 | 4,577,095 | 16,235,132 | 3,479,189 | 3,068,121 | -2,355,091 | 2,987,361 | 5,443,085 | 4,018,840 | 1,091,904 |
| total shareholders funds | -3,530,138 | -163,097 | 26,179 | 3,600,038 | 4,577,095 | 16,235,132 | 3,479,189 | 3,068,121 | -2,355,091 | 2,987,361 | 5,443,085 | 4,018,840 | 1,091,904 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||
| Operating Profit | -2,307,544 | -61,631 | -3,271,335 | -790,501 | -11,422,778 | 133,322,705 | 1,063,681 | 5,173,073 | -5,604,231 | -2,706,393 | 1,187,578 | 2,973,355 | 1,247,402 |
| Depreciation | 94,316 | 94,312 | 94,077 | 100,759 | 102,373 | 83,233 | 72,139 | 64,333 | 54,938 | 19,983 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | -401,155 | -1,113 | -109,740 | -31,633 | -1,289 | -544,376 | -927 | 0 | 10,891 | 0 | 33,525 | -46,419 | -155,499 |
| Stock | 0 | 0 | 0 | -42,791,249 | -38,234,067 | 41,973,261 | -2,522,902 | 2,064,379 | 1,772,829 | -592,364 | 15,471,923 | 4,601,427 | 18,256,763 |
| Debtors | 6,951,128 | 3,805,680 | 2,785,741 | -1,572,681 | -277,756 | -15,463,805 | 3,842,295 | 4,020,411 | -6,226,211 | 9,724,996 | 3,600,187 | 2,993,868 | 3,722,731 |
| Creditors | 425,613 | 600,222 | -438,049 | 1,692,712 | -3,931,272 | 2,767,824 | -78,943 | 181,937 | -2,191,262 | -397,383 | 1,227,889 | 761,654 | 2,294,048 |
| Accruals and Deferred Income | -957,847 | 332,185 | -366,372 | -1,048,477 | 883,104 | 683,181 | -183,252 | 138,183 | 1,014,565 | 428,595 | -158,516 | -284,819 | 456,335 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | -10,097,745 | -2,841,705 | -6,877,160 | 44,286,790 | 24,141,961 | 109,803,111 | -446,695 | -527,264 | -2,261,717 | -11,787,830 | -16,781,634 | -4,191,524 | -18,137,208 |
| Investing Activities | |||||||||||||
| capital expenditure | 0 | 0 | 0 | 0 | 0 | -743,714 | -603,456 | -1,049,559 | 2,420,496 | ||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | 0 | 0 | 0 | 0 | 0 | -743,714 | -603,456 | -1,049,559 | 2,420,496 | ||||
| Financing Activities | |||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | -283,587 | -34,546 | 1,350,731 | 589,177 | -12,858,679 | 12,606,847 | 2,978,104 | 232,499 | 1,465,356 | 52,935,753 | -779,476 | 1,012,571 | 282,929 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -41,157,557 | 18,860,597 | 3,000,001 | 19,296,959 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||||
| interest | 121,371 | 163,064 | 97,143 | 119,830 | -225,533 | 18,178 | -317,893 | 250,139 | 250,888 | 250,669 | 203,142 | 0 | 0 |
| cash flow from financing | -941,929 | -161,078 | 1,157,947 | 434,254 | -13,092,649 | 12,542,989 | 2,326,418 | 482,638 | 1,716,244 | 12,028,865 | 18,284,263 | 4,012,572 | 19,579,889 |
| cash and cash equivalents | |||||||||||||
| cash | 748,727 | -1,403,197 | 132,029 | -11,404,137 | 10,958,423 | 1,643,858 | 1,276,267 | -175,219 | -595,485 | -396,592 | 464,334 | -178,952 | 1,442,681 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 748,727 | -1,403,197 | 132,029 | -11,404,137 | 10,958,423 | 1,643,858 | 1,276,267 | -175,219 | -595,485 | -396,592 | 464,334 | -178,952 | 1,442,681 |
qatar bloodstock limited Credit Report and Business Information
Qatar Bloodstock Limited Competitor Analysis
Perform a competitor analysis for qatar bloodstock limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other mid companies, companies in CB8 area or any other competitors across 12 key performance metrics.
qatar bloodstock limited Ownership
QATAR BLOODSTOCK LIMITED group structure
Qatar Bloodstock Limited has no subsidiary companies.
Ultimate parent company
QATAR INVESTMENT & PROJECTS DEVELOPMENT
#0075067
1 parent
QATAR BLOODSTOCK LIMITED
07422602
qatar bloodstock limited directors
Qatar Bloodstock Limited currently has 3 directors. The longest serving directors include Mr David Redvers (Oct 2010) and Mr Kareem Altaji (Oct 2010).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr David Redvers | 54 years | Oct 2010 | - | Director | |
| Mr Kareem Altaji | England | 58 years | Oct 2010 | - | Director |
| Sheikh Fahad Al Thani | State Of Qatar | 35 years | Oct 2010 | - | Director |
P&L
December 2023turnover
17.7m
+10%
operating profit
-2.3m
+3644%
gross margin
-19.9%
-408.88%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
-3.5m
+20.64%
total assets
59.8m
-0.07%
cash
2.5m
+0.42%
net assets
Total assets minus all liabilities
Similar Companies
qatar bloodstock limited company details
company number
07422602
Type
Private limited with Share Capital
industry
47990 - Other retail sale not in stores, stalls or markets
incorporation date
October 2010
age
15
incorporated
UK
ultimate parent company
accounts
Group
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
LOVEWELL BLAKE LLP
address
lushington house, 119 high street, newmarket, suffolk, CB8 9AE
Bank
WEATHERBYS BANK LIMITED
Legal Advisor
-
qatar bloodstock limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to qatar bloodstock limited.
qatar bloodstock limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for QATAR BLOODSTOCK LIMITED. This can take several minutes, an email will notify you when this has completed.
qatar bloodstock limited Companies House Filings - See Documents
| date | description | view/download |
|---|
